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Abstract 
Ataxin-1 (ATXN1), the gene mutated in spinocerebellar ataxia type 1 (SCA1), may affect 
cognition and mood, but much remains unknown, including which brain areas are 
responsible, whether ATXN1 affects mood in mice, and the mechanisms of these effects. 
To answer these questions, we characterized cognition and mood in several ATXN1 
mutant mouse lines: Atxn1+/- and Atxn1-/- mice to compare 50% and 100% loss of 
ATXN1; Atxn1154Q/2Q and Atxn178Q/2Q mice to compare SCA1-like polyglutamine 
expansions of different lengths; and Purkinje cell specific Pcp2-ATXN1[82Q] mice to 
determine the cerebellar contribution. Atxn1-/- and Atxn1154Q/2Q mice showed cognitive 
deficits. Reduced hippocampal neurogenesis in Atxn1-/- mice may explain this. Cognition 
was not affected in Atxn1+/-, Atxn178Q/2Q, or Pcp2-ATXN1[82Q] mice. We also observed 
mood abnormalities not consistent with depression or anxiety. These results provide a 
foundation for further research into the function of ataxin-1 and the potential side effects 
of reducing ataxin-1 levels to treat SCA1. 
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Introduction 
Ataxin-1 (ATXN1), located on the short arm of chromosome 6, is a highly evolutionarily 
conserved gene which is expressed widely throughout the brain (Banfi et al. 1996). 
ATXN1 encodes the protein ataxin-1 which is thought to contribute to both transcriptional 
regulation and RNA splicing by interacting with transcriptional repressors, such as 
Capicua (CIC) (Lam et al. 2006) and components of the spliceosome, such as RBM17 
(Lim et al. 2008), affecting their activity. This means it is poised to affect a wide variety 
of downstream cellular processes.  
The human ATXN1 gene contains an unstable CAG tract, with the number of CAG 
repeats varying widely between individuals.  Healthy individuals have between 6 and 44 
CAG repeats (Quan, Janas, and Popovich 1995; Matilla et al. 1993), with those above 38 
repeats having one or more CAT interruptions. The CAG tract is translated into a 
polyglutamine tract in the ataxin-1 protein. Long uninterrupted polyglutamine tracts 
(more than 39 residues with no histidine interruptions from CAT codons) affect 
ataxin-1’s aggregation (Watase et al. 2002), degradation (H.K. Chen et al. 2003), and 
interactions with its binding partners (Lim et al. 2008), leading to the fatal 
neurodegenerative disease spinocerebellar ataxia type 1 (SCA1), which is characterized 
by cerebellar degeneration and progressive ataxia (Orr et al. 1993). Because of this, 
ataxin-1 has been studied extensively in the context of disease, while less is known about 
its endogenous function. 
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To look at the endogenous function of a protein, it helps to see what happens when that 
protein is absent. While rare, there are several reported cases of humans born with 
chromosomal deletions that include ATXN1, who all presented with developmental delays 
and autism spectrum disorders (Celestino-Soper et al. 2012). In addition, when ATXN1 is 
knocked out in mice, the animals are largely healthy aside from performing poorly on the 
Morris Water Maze (Matilla et al. 1998). The Morris Water Maze is a test of spatial 
learning and memory in which mice are placed in opaque water and must learn the 
location of a submerged hidden platform to escape the water. While wild-type mice 
learned to find the platform faster with training, the ataxin-1 knockout mice never 
acquired the task even after 17 days of training. Unsurprisingly, in a probe trial where the 
platform was taken away, the knockout mice searched all parts of the maze equally with 
no apparent memory of where the platform used to be, while their WT littermates 
preferentially searched in and around the former location of the platform. These human 
deletion case reports and mouse studies both suggest that ataxin-1 may be important for 
normal cognition.  
Ataxin-1 also appears to play a role in cognition in several disease states. Patients with 
SCA1, which arises from polyglutamine expansion in ataxin-1, can develop cognitive 
symptoms including memory loss and executive function deficits in addition to the more 
well-studied motor impairments caused by the disease (Bürk et al. 2003; Kish et al. 
1988). This is especially noticeable in aggressive juvenile-onset cases, where cognitive 
symptoms are more pronounced and can precede other symptoms (Zoghbi et al. 1988). 
Notably, polymorphism in ataxin-1 has also been linked to Alzheimer’s risk (Bertram et 
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al. 2008). In mice, knocking in an expanded ATXN1 allele with 154 repeats leads to many 
features of SCA1, including progressive ataxia and early death (Watase et al. 2002). Like 
ataxin-1 knockout mice, these Atxn1154Q/2Q mice also display cognitive deficits, as 
measured by the Morris water maze (Watase et al. 2002) and fear conditioning (Watase 
et al. 2007, 2002).  
The fact that both deletion and polyglutamine expansion of ATXN1 cause cognitive 
deficits raises a question regarding ATXN1’s role in cognition: Are the cognitive deficits 
in SCA1 due to toxic gain-of-function in the polyglutamine-expanded ataxin-1 or to loss 
of endogenous ataxin-1 function? This is an important and pressing question to ask—the 
ataxia and premature death associated with polyglutamine expansion in ataxin-1 are 
thought to be toxic gain-of-function effects, because Atxn1-/- mice only develop mild 
motor incoordination and do not die prematurely (Matilla et al. 1998). In addition, 
turning off the expression of the mutant allele in conditional SCA1 trasngenic mice 
alleviates disease phenotypes (Zu et al. 2004). Because of this, promising preclinical 
treatments for SCA1 aim to reduce the levels of mutant ataxin-1 protein to correct these 
features of the disease (Harry Orr, personal communication). However, these treatments 
cannot yet distinguish between wild-type and mutant ataxin-1 and are likely to cause 
some degree of ataxin-1 loss of function. The fact that Atxn1-/- mice have cognitive 
deficits suggests that the loss of ataxin-1 function caused by these treatments could have 
detrimental cognitive side effects.  
A second open question is which brain region(s) contribute to ATXN1’s role in nonmotor 
functions, given that it is expressed throughout the brain (Banfi et al. 1996) but mainly 
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studied in the context of the cerebellum. The cerebellum could, in fact, be responsible for 
these effects of ATXN1—although it was traditionally thought to specialize in motor 
coordination, more recent evidence suggests that the cerebellum also plays a critical role 
in cognition and mood (for review see Koziol et al. 2014 and Bodranghien et al. 2016). 
One line of evidence comes from anatomical and functional connectivity. For example, 
the posterior cerebellum is heavily connected to association and limbic areas (Buckner et 
al. 2011; Stoodley and Schmahmann 2010, 2009), is activated during a wide range of 
cognitive tasks without a heavy motor component (Keren-Happuch et al. 2014), and 
atrophies alongside the frontal cortex in Alzheimer’s disease and frontotemporal 
dementia (Guo et al. 2016). This is supported by case studies in patients with lesions 
affecting the posterior cerebellum. These patients may develop the “cerebellar cognitive 
affective syndrome,” characterized by impaired executive function, poor visuospatial 
cognition, linguistic abnormalities, and personality changes such as impulsive behavior 
(Schmahmann and Sherman 1998; Stoodley et al. 2016; Tedesco et al. 2011). These 
observations have led to the hypothesis that the cerebellum modulates activity from 
diverse cortical areas. In this model, damage to the cerebellum would not only cause 
dysregulated movement but also dysregulated mood and cognition. The cognitive and 
mood features of SCA1 could therefore be a direct result of cerebellar degeneration. 
It is difficult to determine the cerebellar contribution to cognition in human SCA1 
because degeneration is not confined to the cerebellum in SCA1, and other conditions 
with more restricted cerebellar pathology may not be representative of the mechanisms of 
SCA1. For example, a recent longitudinal investigation compared human patients with 
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SCA1, which affects a variety of extracerebellar regions, with patients with SCA6, in 
which degeneration is largely confined to the cerebellum (Moriarty et al. 2016). They 
found that both SCA1 and SCA6 patients developed cognitive deficits as their cerebellar 
motor symptoms progressed, but that cognitive deficits progressed faster in SCA1 
patients. This suggests that the cerebellum plays a major role in cognitive deficits in 
SCA1, but may not be the only contributor. However, the differences observed in 
cognitive symptoms between the SCA1 and SCA6 patients could be due to a number of 
factors, such as faster clinical progression in SCA1 patients, small sample size, different 
cognitive tests used, or differences in the ages of patients tested. Mouse studies would 
allow us to better control for many of these factors, but to our knowledge no cognitive 
study has ever been published on mice in which ATXN1 is manipulated only in the 
cerebellum. 
Even less studied than ATXN1’s role in cognition is its role in mood. Patients with SCA1 
experience high rates of depression compared to the general population (Klinke et al. 
2010; Lo et al. 2016; Schmitz-Hübsch et al. 2011), which can seriously impact their 
quality of life. It is unknown whether this is a direct effect of polyglutamine-expanded 
ataxin-1 or the result of living with a terminal disease; knowing this could help with 
planning approaches to treat depression in SCA1 patients. Mouse studies can help clarify 
this. Indeed, a recent study showed that conditional forebrain knockouts of either Atxn1L 
(a paralogue of ATXN1) on an Atxn1+/- or Atxn1-/- background or of Capicua (a 
transcriptional regulator that interacts with ATNX1) leads to decreased anxiety-like 
phenotypes on the elevated plus maze and open field tests (Lu et al. 2017). However, 
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mouse studies focusing on the effect of ATXN1 itself on mood, particularly depression, 
are lacking. 
Thus, while both mouse and human studies hint at a role for ataxin-1 in cognition and 
mood, several major open questions remain: the mechanisms of ATXN1’s effect—
including the role of loss versus gain of function and the role of the cerebellum versus 
other areas—and whether ATXN1 affects mood in mice at all. This thesis research is 
aimed at better characterizing the learning, memory and mood deficits in ATXN1 mutant 
mice in order to provide answers to these questions.  
In order to investigate these questions, we have used several different strains of mice.  
First, global ATXN1 knockout (Atxn1-/-) mice, in which the majority of the coding region 
(exon 8) of ATXN1 has been removed, can provide us with insight into which phenotypes 
result from a loss of endogenous ATXN1 function. Previous studies have shown that 
homozygous Atxn1 knockout mice are deficient on the Morris water maze (Matilla et al. 
1998), but to our knowledge there is no published data on cognition in heterozygous 
Atxn1 knockout mice despite the recent interest in reducing ataxin-1 levels for SCA1 
treatment. Heterozygous Atxn1+/- mice are a convenient model for testing whether a 50% 
reduction in ataxin-1 protein will impact cognition as a potential side effect, and we have 
therefore included them in all behavioral tests alongside their WT and Atxn1-/- littermates. 
Second, Atxn1154Q/2Q knockin mice, a mouse model of SCA1 in which one allele of the 
ATXN1 gene contains a long CAG tract with 154 repeats, can provide insight into which 
phenotypes result from a toxic gain of function in polyglutamine-expanded ataxin-1 
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(Watase et al. 2002). Atxn1154Q/2Q mice show progressive ataxia, early death, and 
cognitive deficits on the Morris water maze and fear conditioning (Watase et al. 2002). 
We also tested Atxn178Q/2Q knockin mice, in which the CAG tract is 78 repeats long 
(Lorenzetti et al. 2000). These mice do not develop severe progressive ataxia or early 
death, but their repeat is more similar to that seen in humans, in which the largest 
recorded CAG tract in ATXN1 was 82 repeats long (Zoghbi et al. 1988). If Atxn178Q/2Q 
mice do develop cognitive deficits, it would be an interesting illustration of repeat length 
affecting movement, cognition, and mood differently. These mice would also provide a 
more biologically and clinically relevant model for molecular biology studies moving 
forward. Both Atxn1154Q/2Q mice and Atxn178Q/2Q mice can reveal phenotypes which may 
be more relevant to SCA1 than other diseases. In addition, by comparing them to Atxn1-/- 
mice tested by the same experimenter using the same procedures in the same laboratory, 
we can more easily predict which of these phenotypes arise primarily through gain versus 
loss of function. 
Finally, we also investigated cognition and mood in Pcp2-Atxn1[82Q] mice, another 
SCA1 model in which an expanded ATXN1 allele with 82 CAG repeats is overexpressed 
selectively in cerebellar Purkinje neurons under the Purkinje cell protein 2 (Pcp2) 
promoter. These mice develop progressive ataxia but not premature death, suggesting that 
ataxia arises predominantly through cerebellar dysfunction but that this cerebellar 
dysfunction alone is not fatal (Burright et al. 1995). Similarly, they can help reveal which 
brain regions are important to ATXN1’s role in cognition and mood by providing us with 
a strain in which mutant ATXN1 is confined to cerebellar Purkinje neurons.  
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We tested learning and memory in these four strains of mice using the Barnes maze and 
context fear conditioning. We also present the first studies on mood in many of these 
strains, using the elevated plus maze to test for an anxiety-like phenotype and the forced 
swim and sucrose preference tests to test for a depression-like phenotype. In addition, we 
show that ATXN1 plays a role in regulating adult hippocampal neurogenesis, a crucial 
hippocampal function which may underlie some of the learning and memory phenotypes 
we observe. 
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Results 
Important note: We experienced some technical difficulties in gathering this data, most 
notably leaks and spills interfering with collection of sucrose preference data and poor 
performance of wild-type mice on tests of learning and memory in some cohorts. Most 
individual mice which experienced obvious problems which interfered with the test have 
been excluded from analysis (see the methods sections of each chapter for details), but 
not all of the data have been thoroughly vetted for inclusion at the time of writing. These 
results should therefore be considered preliminary and subject to change. 
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Chapter 1: Cognition and mood in Atxn1-/- mice 
Introduction 
Evidence from both human and mouse studies points to a role for ATXN1 in cognition. In 
humans, chromosomal deletions containing ATXN1 cause developmental delays and 
autism spectrum disorders (Celestino-Soper et al. 2012). Patients with spinocerebellar ataxia 
type 1 (SCA1), which is caused by expansion of a CAG repeat in ATXN1, are also prone to 
developing mild cognitive deficits (Bürk et al. 2003). In mice, deletion of the majority of 
the coding region of the ATXN1 gene (exon 8) leads to severe deficits on the Morris water 
maze, a test of spatial learning and memory (Matilla et al. 1998). Here we attempt to 
replicate these results on the Barnes maze and context fear conditioning, including both 
homozygous (Atxn1-/-) and heterozygous (Atxn1+/-) ATXN1 knockout mice to test whether 
a partial reduction in ATXN1 can also cause cognitive deficits. 
In addition to cognition, ATXN1 may also play a role in mood. We therefore performed 
standard tests of depression- and anxiety-like phenotypes on Atxn1-/- and Atxn1+/- mice to 
better determine what role ATXN1 plays in regulating multiple types of mood. 
Methods 
Mice. Atxn1-/- mice (Matilla et al. 1998) on a C57/Bl6 background were a gift from the 
laboratory of Dr. Huda Zoghbi. Mice were housed in a temperature- and humidity-
controlled room on a 12 hour light/12 hour dark cycle with access to food and water ad 
libitum. Behavioral experiments were performed during the light phase of the cycle. 15 
WT, 22 Atxn1+/-, and 11 Atxn1-/- mice of both sexes, age 8-12 weeks, were used. Mice 
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went through a battery of tests, with the same order of testing for all mice (in order: 
elevated plus maze, forced swim test, Barnes maze, fear conditioning, sucrose 
preference). All animal experiments were performed in compliance with the National 
Institutes of Health’s Guide for the Care and Use of Laboratory Animals and the 
University of Minnesota Institutional Animal Care and Use Committee. 
Barnes maze. The maze was a white circular platform 91 cm in diameter with 20 5-cm 
circular holes spaced evenly around the edge, raised approximately 92 cm above the 
floor. One of the holes led to a 5 cm wide x 11 cm long x 5 cm deep opaque box (the 
“escape box”) and the other 19 were covered. The testing room had visual cues on the 
walls to serve as landmarks, and all objects in the room were kept in the same places for 
every trial. During the training trials, the mouse was placed under an opaque plastic 
bucket in the center of the maze with the lights turned off for approximately 10 seconds. 
The lights were turned on, the bucket was removed, and the mouse was allowed to 
explore the maze for 3 minutes or until it entered the escape box, after which the escape 
box was covered and the mouse allowed to sit in it for approximately 1 minute before 
being returned to its home cage. The position of each mouse was tracked using AnyMaze 
software. Mice which did not enter the escape box within 3 minutes were gently guided 
to it. Mice were exposed to the maze for four consecutive training days (four trials per 
day with an intertrial interval of approximately 15 minutes). Training day data is reported 
as path length (distance traveled before entering the escape hole) and analyzed by two-
way repeated measures ANOVA. A probe test was conducted 24 hours after the last 
training session. For the probe test, the escape hole was covered and each mouse was 
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allowed to explore the maze freely for 90 seconds. The time spent in each quadrant of the 
maze was recorded, and the amount of time spent in the goal quadrant (the quadrant 
centered on the goal hole) was analyzed by one-way ANOVA.  
Search strategies on the training days were classified automatically into six categories 
using the Barnes maze unbiased strategy (BUNS) classification tool (Illouz et al. 2016). 
Each strategy was also assigned a “cognitive score” between 0 and 1 (Direct=1.0, 
Corrected=0.75, Long correction=0.5, Focused search=0.5, Serial=0.25, Random=0.0). 
This scoring scale was taken from Illouz et al. 2016 and is based on how similar the 
strategy is to the optimal “Direct” strategy, as determined by a k-means clustering 
analysis. In order to compare learning rates between groups, cognitive scores for each 
mouse on each of the 16 training trials were plotted in GraphPad Prism 7.0. Linear 
regression was performed for each group and the slopes and elevations of the lines were 
compared using Prism’s Analysis function.   
Context fear conditioning. Conditioning took place in chambers with a floor consisting of 
stainless steel rods through which shocks were delivered (Med Associates #ENV-008-
FPU-M). On day 1, mice were placed in the chambers for a 10-minute period during 
which they received five foot shocks (0.70 mA, 2-second duration). Freezing during the 
60 seconds after each shock was quantified automatically using VideoFreeze software 
(freezing was defined as a motion index ≤15 lasting ≥500 ms). 24 hours after the initial 
conditioning, mice were returned to the same chambers with the shock generators turned 
off and freezing behavior was monitored for 3 minutes. 1-2 hours after being placed in 
the conditioned context, mice were placed in a second context for 3 minutes to measure 
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baseline freezing. The baseline context used the same chambers but differed from the 
conditioned context in floor texture (smooth plastic versus metal rods), shape (curved 
plastic wall versus square metal wall), and odor (0.5% vanilla extract versus 33% Simple 
Green). The white house lights and NIR lights were on during both conditioning and 
recall. Acquisition of freezing responses is reported as percent freezing in the 60-second 
period following each of the 5 foot shocks, analyzed by two-way repeated measures 
ANOVA. 24-hour recall is reported as percent freezing in each context over the 3-min 
test period, analyzed by two-way repeated measures ANOVA. 
Elevated plus maze. The maze was approximately 76 cm across and consisted of two 
open arms (6.3 cm x 34.2 cm) and two closed arms (6.3 cm x 34.2 cm with 19 cm tall 
opaque walls) extending from a 6.3 cm x 6.3 cm center area, raised 96 cm above the 
floor. The surrounding room was dark and the maze was lit by overhead lights. Light 
intensity in the open arms was 45-50 lux, and in the closed arms was 3-6 lux. Each mouse 
was placed in the center of the maze facing an open arm and allowed to explore for 5 
minutes. During this time, the mice were tracked automatically using AnyMaze software 
and the time spent in each zone (open arms, closed arms, center area) was recorded. The 
maze was cleaned with 70% ethanol before each mouse. The time spent in each zone was 
analyzed using one-way ANOVA. 
Forced swim test. Mice were placed in a transparent cylindrical container (diameter 18.4 
cm, height 23.5 cm) filled to a depth of approximately 15 cm with water at 24-26°C. 
They swam for six minutes before being removed from the water and placed in a cage 
containing absorbent material on a heating pad to dry off. Time immobile was tracked 
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automatically using AnyMaze software (immobility was defined as a period of 85% or 
greater immobility lasting 250 ms or longer). The time spent immobile in seconds during 
the last 4 minutes of the test is presented here, analyzed by one-way ANOVA. 
Sucrose preference test. Mice were singly housed in cages with cotton nestlets (instead of 
shredded paper, which is standard in our mouse facility but can easily sit against water 
bottle spouts and absorb water) in order to allow for accurate measurement of each 
mouse’s water and sucrose consumption. Mice were acclimated to solitary housing for 
3 days before the test. On the first day of testing, each mouse was given two bottles of 
water to test for any bias towards one side of the cage. On each day following this, each 
mouse was given one bottle containing water and another one containing either 2% or 4% 
sucrose. Bottles were weighed every 24 hours to measure the amount of liquid consumed. 
Results for the 4% sucrose day, for which we saw the greatest differences between 
groups, are reported here, analyzed by two-way ANOVA. 
Excluded mice. No mice were excluded from the Barnes maze, although individual 
training trials were removed whenever the software failed track the mouse’s location. 
One Atxn1+/- and one Atxn1-/- mouse were excluded from fear conditioning analysis 
because of excessive handling (they were removed from the chambers and returned after 
calibrating the camera, a step which should have been done before putting the mice in the 
chambers). On the elevated plus maze, one WT mouse was excluded after being moved 
to a new cage with new cagemates shortly before testing; one Atxn1-/- mouse failed to 
explore the maze; one WT mouse jumped off of the maze; and one Atxn1+/- mouse was 
excluded because the room lights came on during testing. One Atxn1+/- mouse was 
15 
 
excluded from the forced swim test analysis because the software did not track it well. On 
the sucrose preference test, one Atxn1-/- and one Atxn1+/- mouse were excluded due to 
large spills discovered in the cage. In addition, one large cohort showed relatively high 
total volumes consumed and is suspected of experiencing spills, but was left in for the 
current analysis as no wet spots were observed in the cages. 
Results 
We tested whether loss of ataxin-1 affects cognition in both homozygous (Atxn1-/-) and 
heterozygous (Atxn1+/-) ATXN1 knockout mice. Mice were tested in a battery of tests 
from 8-12 weeks of age. This age is both convenient for testing and relevant to potential 
side effects in preclinical testing, as several SCA1 model mouse lines begin to develop 
ataxia by approximately 12 weeks of age. 
In order to test cognition in Atxn1-/- mice we used two different tests: the Barnes maze 
and context fear conditioning. The Barnes maze is a dry-land version of the Morris water 
maze in which mice must learn and remember the location of an opening to escape an 
open field (Barnes 1979). We chose the Barnes maze over the Morris water maze for two 
reasons. First, it only requires walking and not swimming, making it less demanding on 
mice which may be experiencing subtle motor deficits. Second, the Barnes maze is both 
less stressful on mice and less sensitive to test-related stress (Harrison, Hosseini, and 
McDonald 2009).  
For the Barnes maze, mice were subjected to four training trials a day for four days to 
learn the location of the escape box, followed by a probe trial on the fifth day where the 
escape box was removed to test their recall. Figure 1A shows the performance of Atxn1-/- 
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mice on each of the training days, presented as path length (the distance traveled by the 
mouse before reaching the escape box). A shorter path length indicates a more efficient 
route to the escape box and better memory. We chose to use this measure rather than the 
more commonly reported latency to escape (the time it takes mice to reach the escape 
box)  because there is some evidence that Atxn1-/- mice may have subtle motor deficits, 
which could impact their running speed and thus their latency (Matilla et al. 1998). 
Indeed, we observed a significant effect of genotype on speed during the training days 
(two-way RM ANOVA, F(2,45) = 4.741, P=0.0135, n=15 WT, 22 Atxn1
+/-, and 11 Atxn1-/- 
mice)—a potentially serious confound for latency.  
Mice in each group improved in path length over the four training days, as seen by a 
significant main effect of day in a 2-way repeated measures ANOVA (F(3,135) = 28.38, 
p<0.0001) with each group showing significant differences between day 1 and day 4 
using Tukey’s post hoc test (WT day 1 average 2.333 m, day 4 0.9299 m, p<0.0001, 
n=15; Atxn1+/- day 1 average 2.645 m, day 4 0.9552 m,  p<0.0001, n=22; Atxn1-/- day 1 
average 2.569 m, day 4 1.358 m, p=0.0019, n=11). This indicates that Atxn1+/- and 
Atxn1-/- mice are motivated to find the escape hole and capable of acquiring the task. 
Although the Atxn1-/- mice had the highest mean path length on day 4, this trend was not 
significant, as we detected no significant effect of genotype (F(2,45)=2.385, p=0.1036) or 
of a genotype x day interaction (F(6,135)=0.7585, p=0.6038) on path length. 
For the probe trial, the escape hole was covered and the mice were allowed to explore the 
maze for 90 seconds. Memory is represented by the amount of time the mouse spends in 
each quadrant of the maze; a mouse which remembers the former location of the escape 
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box will spend more time looking for it in the correct goal quadrant than in the other 
three quadrants. We detected a significant effect of genotype on time spent in the goal 
zone by one-way ANOVA (F(2, 45) = 11.35, p=0.0001). Atxn1
-/- mice—but not Atxn1+/- 
mice—performed significantly worse than WT (average time in goal quadrant: 
WT 37.62 s, Atxn1+/- 41.26 s, Atxn1-/- 25.58 s, p = 0.4521 for WT vs Atxn1+/- and 0.0042 
for WT vs Atxn1-/-, Tukey’s multiple comparisons test, Figure 1B). 
The fact that Atxn1-/- mice improve over the training days but still perform poorly on the 
probe trial can be interpreted in multiple ways. They may have learned the location of the 
escape box quickly over the four trials each day but failed to remember it 24 hours later 
on the probe trial, or they may have learned to find the escape box through some means 
other than using spatial cues in the room. Indeed, wild-type mice can improve on multiple 
measures of Barnes maze performance over training even when the escape box is moved 
to a new semi-random location each trial (O’Leary and Brown 2013). In this case, they 
often develop a serial search strategy, in which they simply run around the edge of the 
maze checking each hole in series until the correct one is found. This allows them to 
efficiently search the maze even without learning the location of the goal relative to 
spatial cues. To test for this possibility, we used the Barnes maze unbiased strategy 
(BUNS) classification tool developed by Illouz et al. (2016) to automatically classify the 
search strategy used by each mouse on each training trial. Strategies were sorted into six 
categories: 1) Direct, in which the mouse takes the most efficient path directly to the 
goal; 2) Corrected, in which the mouse first goes toward one of the holes adjacent to the 
goal and makes a correction to reach the goal; 3) Long correction, in which the mouse 
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first moves toward a hole far from the goal and then turns around and goes directly to the 
goal; 4) Focused search, in which the mouse scans a larger area near the goal, 5) Serial, in 
which the mouse goes around the maze checking each hole in series, and 6) Random, in 
which the mouse takes a long and inefficient path with no obvious pattern.  
Figure 1C shows example path plots from our mice using each of these strategies, as well 
as group data over the four training days (16 trials total) for wild type, Atxn1+/-, and 
Atxn1-/- mice. Nearly all mice took a random path on the first trial, when they were naive 
to the maze. This was quickly replaced by more efficient strategies as mice learned the 
task. Mice tended to pass through a serial search stage, which was later replaced partially 
by strategies which rely on knowledge of where the hole is located in space (i.e. Direct, 
Corrected, Long correction, and Focused search).  
In order to quantify the rate at which the mice learned the spatial strategies, each strategy 
was assigned a “cognitive score” based on how similar it is to the optimal “Direct” 
strategy (Direct=1.0, Corrected=0.75, Long correction=0.5, Focused search=0.5, 
Serial=0.25, Random=0.0, see Illouz et al. 2016 for details). The cognitive score for each 
mouse was plotted as a function of trial number and regression lines were fitted to each 
group (WT: Y = 0.02549*X + 0.1124, Atxn1+/-: Y = 0.02494*X + 0.05666, 
Atxn1-/-: Y = 0.02024*X + 0.08211). Although the Atxn1-/- group had the lowest slope, this 
difference was not statistically significant (F2,751=0.4775, p=0.6205). This indicates that 
all three groups of mice learned more effective search strategies at similar rates. There 
was, however, a statistically significant difference in the elevations of the lines 
(F2,753=5.01, p=0.0069). This could indicate that, while all groups improved at the same 
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rate, the WT mice were using better strategies overall across all timepoints, and may 
warrant further investigation. 
These results suggest that Atxn1-/- mice can learn to use spatial cues to find the goal, but 
do not retain this information well on the probe trial, in contrast with previous research 
using the Morris water maze which suggested that they never acquire the task during 
training (Matilla et al. 1998). The discrepancy between our findings and those of Matilla 
et al. may be due to differences in the two tests used: for example, in the Barnes maze, all 
holes are located around the edge of the maze, allowing all possible goal locations to be 
searched efficiently, while in the Morris water maze the goal could be in a wider variety 
of locations. 
We used the Barnes maze because it is similar in design to the Morris water maze, which 
revealed severe learning and memory deficits in both Atxn1-/- mice and Atxn1154Q/2Q mice 
in previous studies (Matilla et al. 1998; Watase et al. 2002). However, it is not 
necessarily the best test of learning and memory in these mice, due to its dependence on 
motor ability and the possibility of solving the task through nonspatial strategies. Because 
of this, we also tested learning and memory in Atxn1-/- mice with context fear 
conditioning.  In context fear conditioning, mice receive footshocks in one context and 
are tested for freezing responses 24 hours later in both the original conditioned context (a 
square space with metal walls and a metal grate on the floor, scented with Simple Green) 
and a control context (with a curved plastic wall and flat plastic floor, scented with 
vanilla extract). Freezing in the conditioned context but not the control context in a recall 
test 24 hours after conditioning indicates learning.  
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Figure 1D shows the acquisition of freezing responses during conditioning in WT, 
Atxn1+/-, and Atxn1-/- mice. All groups greatly increased their freezing over the course of 
conditioning (significant effect of shock number by 2-way repeated measures ANOVA, 
F(4,172)=95.85, p <0.0001, n=15 WT, 21 Atxn1
+/-, and 10 Atxn1-/- mice), indicating that 
they are able to feel the shock and freeze in response to multiple inescapable shocks. 
However, there was also a significant effect of genotype on freezing (F(2,43)=3.576, 
p=0.0366). Atxn1-/- mice froze less during the last part of conditioning than Atxn1+/- mice 
(45.19% freezing in Atxn1+/- during the 60 s following the last shock vs 29.99% in 
Atxn1-/- mice, p=0.0311, Tukey’s multiple comparisons test), indicating a possible change 
in freezing behavior which complicates the interpretation of 24-hour recall results. 
When tested for recall 24 hours later (Figure 1E), all groups froze significantly more in 
the conditioned context than in a control context (significant main effect of context by 
two-way repeated measures ANOVA, F(1,43)=85.96, p<0.0001, n=15 WT, 21 Atxn1
+/-, 
and 10 Atxn1-/- mice). There was also a significant effect of genotype (F(2,43)=6.061, 
p=0.0048) with the Atxn1-/- mice freezing less than wild-type in the conditioned context 
(WT average 40.92% freezing, Atxn1-/- average 19.7% freezing, p=0.0088, Sidak’s 
multiple comparisons test). There was a trend towards Atxn1-/- mice freezing less in the 
baseline context as well, but this did not reach statistical significance (WT average 
15.98% freezing, Atxn1-/- average 4.9% freezing, p=0.3033, Sidak’s multiple comparisons 
test). Heterozygous Atxn1 knockout mice did not differ from wild type in either the 
conditioned context (WT average 40.92% freezing, Atxn1+/- average 46.14% freezing, 
p=0.7488, Sidak’s multiple comparisons test) or the baseline context (WT average 
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15.98% freezing, Atxn1+/- average 18.12% freezing, p=0.9758, Sidak’s multiple 
comparisons test). These results may indicate a memory deficit in the Atxn1-/- mice but 
not the Atxn1+/- mice, in agreement with the Barnes maze results. However, caution 
should be used when interpreting the fear conditioning results alone, given the tendency 
of Atxn1-/- mice to freeze less during conditioning and the trend towards Atxn1-/- mice 
freezing less in the baseline context. 
In addition to cognitive tests, we also examined mood in ATXN1-deficient mice using 
three different tests: the elevated plus maze to test for an anxiety-like phenotype 
(Handley and Mithani 1984), and the forced swim (Porsolt, Bertin, and Jalfre 1977) and 
sucrose preference tests (Willner et al. 1987) to test for a depression-like phenotype. 
The elevated plus maze consists of a plus-shaped platform with two “closed” arms 
(which are enclosed by tall opaque walls and are dimly lit) and two “open” arms (which 
have no walls and are more brightly lit). As small prey animals, mice prefer dark 
enclosed spaces to brightly lit open spaces and are therefore expected to be more 
comfortable in the closed arms. However, they will still explore the novel environment of 
the open arms to some extent. A reduction in time spent exploring the open arms is 
thought to indicate an anxiety-like phenotype. On the elevated plus maze, we saw a 
significant effect of genotype on open arm time (One-way ANOVA, F(2,39) = 5.341, 
p=0.0070, n=13 WT,  21 Atxn1+/-, and 9 Atxn1-/- mice, Figure 2A). Atxn1-/- mice spent 
more time in the open arms than heterozygous knockout mice (Atxn1-/- average 40.72 sec, 
Atxn+/- average 15.88 sec, p=0.068, Holm-Sidak’s multiple comparison test), indicating a 
possible reduction in anxiety-like phenotype, though this trend was not statistically 
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significant relative to wild-type (Atxn1-/- average 40.72 sec, WT average 23.9 sec, 
p=0.1025, Holm-Sidak’s multiple comparison test).  
The forced swim test measures an animal’s response to an inescapable negative situation, 
and is thought to relate to the predisposition to negative mood and pessimism seen in 
human depression. Mice are placed in water in a chamber they cannot climb out of and 
swim for several minutes. In this situation, the mice will spend periods of time struggling 
to escape and other periods of time floating immobile in the water. Increased immobility 
time indicates a shift from active coping strategies to passive coping strategies—one 
component of a depression-like phenotype. We saw a significant effect of genotype on 
immobility time by one-way ANOVA (F(2,44)= 17.17, p<0.0001, n= 15 WT, 21 Atxn1
+/-, 
and 11 Atxn1-/- mice, Figure 2B). Interestingly, this was because Atxn1-/- mice were less 
immobile than their WT and Atxn1+/- littermates, indicating that Atxn1 knockout in mice 
may alter mood in a less straightforward way than simply causing a depression-like 
phenotype (WT average 164.2 sec, Atxn1+/- average 160.6 sec, Atxn1-/- average 106.5 sec, 
p<0.0001 for Atxn-/- vs both WT and Atxn1+/-, Holm-Sidak’s multiple comparison test).  
The sucrose preference test is thought to measure anhedonia, or lack of interest in 
pleasurable things, which is another feature of depression. Mice are given two bottles 
containing water and sucrose, respectively, and the amount of liquid they consume from 
each bottle is measured. Mice generally prefer sucrose over water; a reduction in sucrose 
preference indicates an anhedonia-like phenotype. Using two-way repeated measures 
ANOVA, we did not detect a significant effect of genotype (F(2,19) = 0.6058, P=0.5558) 
or of a genotype x sucrose interaction (F(2,19) = 0.5208, P=0.6023) on sucrose 
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consumption in Atxn1+/- or Atxn1-/- mice (Figure 2C). However, due to technical 
difficulties with leaking bottle lids for one large cohort of mice, we did not have enough 
data to draw strong conclusions.  
Thus, based on our forced swim test and preliminary sucrose preference results, we may 
see an alteration in mood and/or coping strategy in Atxn1-/- mice, but this may not be 
related to a depression-like phenotype per se. 
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Figure 1. Atxn1-/- mice perform poorly on tests of learning and memory. A) Average path length for each of the 
four Barnes maze training days in 9-10-week-old WT, Atxn1+/-, and Atxn1-/- mice. (2-way ANOVA). B) Time spent in 
the goal zone during the probe trial for 9-10-week-old WT, Atxn1+/-, and Atxn1-/- mice (1-way ANOVA). C) Barnes 
maze search strategy use (left) and corresponding cognitive scores (right) over the four training days in 9-10 week old 
WT, Atxn1+/- and Atxn1-/- mice. D) Acquisition of freezing responses during context fear conditioning in 10-11 week 
old WT, Atxn1+/- and Atxn1-/- mice, reported as percent freezing during the 60-second interval after each shock (2-way 
ANOVA). E) Fear conditioning 24-hour recall in a baseline context and the conditioned context for 10-11 week old 
WT, Atxn1+/- and Atxn1-/- mice (2-way ANOVA). Data are presented as mean ± SD.  
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Figure 2. Mood in Atxn1+/- and Atxn1-/- mice. A) Elevated plus maze in 8-9 week old WT, Atxn1+/- and 
Atxn1-/- mice. The time spent in the open arms (left), closed arms (center) and center of the maze (right) is 
shown (one-way ANOVA). B) Forced swim test in 8-9 week old WT, Atxn1+/- and Atxn1-/- mice, reported 
as time spent immobile in the last 4 minutes of the test (one-way ANOVA). C) Water and sucrose 
consumption in the sucrose preference test in 11-12 week old WT, Atxn1+/- and Atxn1-/- mice (two-way 
ANOVA). Data are presented as mean ± SD.  
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Chapter 2: Cognition and mood in Atxn1154Q/2Q and Atxn178Q/2Q knockin 
mice 
Introduction 
In order to test the effects of polyglutamine-expanded ataxin-1 on cognition and mood in 
mice, which may be relevant to SCA1 patients experiencing cognitive deficits and mood 
alterations, we used Atxn1154Q/2Q knockin mice. These mice have one copy of the mouse 
ATXN1 gene with an extremely long CAG repeat (154 repeats) knocked into the 
endogenous locus, and one wild-type copy of mouse ATXN1 with 2 CAG repeats (Watase 
et al. 2002). Atxn1154Q/2Q mice have previously been reported to have deficits on the 
Morris water maze (Watase et al. 2002, 2007) and fear conditioning (Watase et al. 2007). 
We aimed to confirm these previous findings of cognitive deficits in Atxn1154Q/2Q mice, 
compare them to Atxn1-/- mice from the same laboratory to determine the relative 
contributions of loss- versus gain-of-function mechanisms, and investigate the effects on 
mood. Because these mice develop progressive ataxia as they age, behavioral tests were 
conducted on mice between 8 and 12 weeks of age, in the hopes of testing them after they 
become old enough to complete the tests easily but before motor deficits can interfere 
with results. 
One caveat of using Atxn1154Q/2Q mice is that their mutant ataxin-1 has a longer 
polyglutamine tract than any found in human SCA1 patients. They were engineered after 
Atxn178Q/2Q knockin mice, modeled after the longest polyglutamine tract ever found in a 
human (82Q), failed to develop any noticeable motor features of SCA1 (Lorenzetti et al. 
2000). However, cognition and mood have never been tested in Atxn178Q/2Q mice to our 
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knowledge. We therefore included them in our study to determine whether the more 
natural and biologically relevant 78Q polyglutamine tract might be sufficient to cause 
cognitive deficits or mood disturbances. These mice were tested at the same ages as the 
Atxn1154Q/2Q mice to make it easier to compare them. 
Methods 
Animals. Atxn1154Q/2Q knockin mice (Watase et al. 2002) and Atxn178Q/2Q knockin mice 
(Lorenzetti et al. 2000) were gifts from the laboratory of Dr. Harry Orr. They were 
generated as previously described on an FVB background and backcrossed onto a 
C57/Bl6 background. All experimental mice tested negative for the homozygous Pde6 
mutation which causes blindness in FVB mice. Male and female mutant mice from each 
strain as well as their wild-type littermates were used. Mice were 8-12 weeks old during 
testing.  
Behavioral tests and statistical analysis. The Barnes maze, context fear conditioning, 
elevated plus maze, forced swim, and sucrose preference tests were conducted and 
analyzed as described above (see Chapter 1), except that t-tests were used in place of one-
way ANOVA for comparisons between two groups. On the forced swim test, the data for 
the Atxn1154Q/2Q mice was not normally distributed and was analyzed with a Mann-
Whitney test rather than a t-test. 
Excluded mice: Atxn1154Q/2Q. No mice were eliminated from the Barnes maze. Three mice 
(one WT and two Atxn1154Q/2Q) were removed from the fear conditioning analysis 
because the chambers were not scented with Simple Green during conditioning. On the 
elevated plus maze, one Atxn1154Q/2Q mouse spent most of the test immobile in a closed 
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arm and was excluded from analysis. In addition, one WT and one Atxn1154Q/2Q mouse 
were excluded because of technical difficulties leading to excess handling (taking them 
off of the maze and putting them back on). On the forced swim test, one Atxn1154Q/2Q 
mouse was a poor swimmer and had to be rescued before the test was finished. One WT 
mouse was excluded because the software did not track it well. Two WT and one 
Atxn1154Q/2Q mouse were eliminated from the sucrose preference test because of leaking 
bottles. 
Excluded mice: Atxn178Q/2Q. One WT mouse was excluded from the Barnes maze after 
freezing in place for most of the probe trial. During fear conditioning, two mice (one WT 
and one Atxn178Q/2Q) clung to the walls of the chambers and avoided shocks, two WT 
mice were excluded because the chamber was not scented with Simple Green during 
conditioning, and one WT mouse escaped from the testing rig after conditioning and was 
excluded from further testing. On the forced swim test, one WT and one Atxn178Q/2Q 
mouse were excluded because the software did not track them, and four mice (two WT 
and two Atxn178Q/2Q) were excluded after they were taken out of the water and put back in 
when correcting technical difficulties. Three WT mice were excluded from the sucrose 
preference test due to leaks and spills. 
Results 
Atxn1154Q/2Q knockin mice 
Figure 3 shows learning and memory in Atxn1154Q/2Q mice. Both wild-type and 
Atxn1154Q/2Q mice improved during training in the Barnes maze (Figure 3A), as evidenced 
by decreased path length over the four training days (significant effect of day by two-way 
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RM ANOVA, F(3,81) = 22.37 P<0.0001). Two-way ANOVA also revealed a significant 
effect of genotype (F(1,27) = 4.47 P=0.0439). Atxn1
154Q/2Q mice showed a trend towards 
longer path length, but no single day was statistically significant after correcting for 
multiple comparisons. Atxn1154Q/2Q mice initially had lower speed than WT mice on day 1 
(two-way ANOVA followed by Sidak’s multiple comparisons test, WT average 0.06593 
m/s, Atxn1154Q/2Q average 0.0399 m/s, p=0.0001), suggesting a potential effect of motor 
impairment. However, this is unlikely to have impacted their ability to learn the maze on 
subsequent days, as they reached roughly wild-type speeds by day 2 (two-way ANOVA 
followed by Sidak’s multiple comparisons test, WT average 0.05919 m/s, Atxn1154Q/2Q 
average 0.05423 m/s, p=0.8778). In the probe trial (Figure 3B), Atxn1154Q/2Q mice 
performed poorly compared to WT (WT average 33.72 sec in goal zone, n=17, 
Atxn1154Q/2Q average 23.42 sec, n=13, p=0.0040, t-test), much like Atxn1-/- mice (see 
Figure 1B).  
Analysis of search strategies on the four training days showed that, while wild-type mice 
adopted more spatial strategies (i.e. Direct, Corrected, Long correction, and Focused 
search) over time, Atxn1154Q/2Q mice relied heavily on a serial search strategy (circling the 
edge of the maze, checking each hole in succession until the escape box is found) even on 
the last trial on day 4 (Trial 16: WT 76% spatial strategies, 6% serial, and 18% random, 
n=17; Atxn1154Q/2Q 0% spatial strategies, 92% serial, and 8% random, n=13; Figure 3C). 
When strategy use was converted to cognitive scores and fitted with regression lines 
(WT: Y = 0.03224*X + 0.06324, Atxn1154Q/2Q: Y = 0.01695*X + 0.04689), WT mice 
improved their scores at a significantly faster rate than Atxn1154Q/2Q mice (significantly 
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different slopes for the two regression lines, F(1,474)=10.2, p=0.0015). This suggests that, 
while Atxn1154Q/2Q mice are capable of learning that the escape box exists and navigating 
to it as efficiently as possible with a non-spatial strategy, they never learn the location of 
the box relative to spatial cues in the room and therefore cannot find the goal hole when it 
is hidden in the probe trial. This is different from the Atxn1-/- mice, which show spatial 
learning but fail to retain the information. 
During context fear conditioning (Figure 3D), Atxn1154Q/2Q mice acquired freezing 
responses similarly to wild-type mice, with no significant effect of genotype (F(1,24) = 
1.46, p = 0.2387, n = 16 WT and 13 Atxn1154Q/2Q) or genotype x shock interaction 
(F(4,96) = 2.118, P=0.0844) by two-way repeated measures ANOVA. However, when their 
recall was tested 24 hours later, they did not freeze any more in the conditioned context 
than in the baseline context—demonstrating a profound memory deficit relative to their 
wild-type littermates (baseline context: WT average 13.87% freezing, Atxn1154Q/2Q 
average 13.82% freezing, p>0.9999; conditioned context: WT average 33% freezing, 
Atxn1154Q/2Q average 13.45% freezing, p=0.0005, 2-way ANOVA followed by Sidak’s 
multiple comparisons test, n= 15 WT and 11 Atxn1154Q/2Q mice, Figure 3E).  
Figure 4 shows performance on the elevated plus maze, forced swim test and sucrose 
preference test in Atxn1154Q/2Q mice. On the elevated plus maze, Atxn1154Q/2Q mice spent 
less time in the center of the maze (WT average 100.7 sec,  Atxn1154Q/2Q average 52.36 
sec, p<0.0001, t-test, n=14 WT and 10 Atxn1154Q/2Q mice), coinciding with more time in 
the closed arms (WT average 155.1 sec,  Atxn1154Q/2Q average 194 sec, p=0.0341, t-test, 
n=14 WT and 10 Atxn1154Q/2Q mice, Figure 4A). Time in the open arms varied widely 
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between individuals and was not statistically significantly different from wild-type (WT 
average 44.21 sec, Atxn1154Q/2Q average 53.65 sec, p=0.5485, t-test, n=14 WT and 10 
Atxn1154Q/2Q mice). The increase in closed arm time, however, suggests an anxiety-like 
phenotype in the Atxn1154Q/2Q mice.  
Atxn1154Q/2Q mice did not differ from their wild-type littermates in the forced swim test 
(WT median 161.2 sec, Atxn1154Q/2Q median 157.3 sec, p=0.2171, Mann-Whitney test, 
n=15 WT and 11 Atxn1154Q/2Q mice, Figure 4B). On the sucrose preference test (Figure 
4C), we saw a significant genotype x sucrose interaction (two-way RM ANOVA, F(1,25) = 
7.655, P=0.0105, n= 15 WT and 12 Atxn1154Q/2Q mice). Atxn1154Q/2Q mice consumed 
significantly more sucrose than wild-type littermates (WT average 9.319 g, Atxn1154Q/2Q 
average 12.79 g, p= 0.0028, Sidak’s multiple comparisons test), while water consumption 
stayed the same (WT average 4.009 g, Atxn1154Q/2Q average 3.199 g, p= 0.6786, Sidak’s 
multiple comparisons test). 
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Figure 3. Atxn1154Q/2Q mice perform poorly on tests of learning and memory. A) Barnes maze average 
path length on each of the four training days for 9-10 week old WT and Atxn1154Q/2Q knockin mice (2-way 
ANOVA). B) Barnes maze probe trial (percent time spent in each zone) for 9-10 week old WT and 
Atxn1154Q/2Q  knockin mice. (2-way ANOVA). C) Barnes maze search strategy use (left) and corresponding 
cognitive scores (right) over the four training days in 9-10 week old WT and Atxn1154Q/2Q knockin mice. D) 
Acquisition of freezing responses during context fear conditioning in 10-11 week old WT and Atxn1154Q/2Q 
knockin mice, reported as percent freezing during the 60-second interval after each shock (2-way 
ANOVA). E) Fear conditioning 24 hour recall in a baseline context and the conditioned context for 10-11 
week old WT and Atxn1154Q/2Q knockin mice (2-way ANOVA). Data are presented as mean ± SD.  
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Figure 4. Mood in Atxn1154Q/2Q mice. A) Elevated plus maze in 8-9 week old WT and Atxn1154Q/2Q knockin 
mice. The time spent in the open arms (left), closed arms (center) and center of the maze (right) is shown. 
Atxn1154Q/2Q (t-test). B) Forced swim test in 8-9 week old WT and Atxn1154Q/2Q knockin mice, reported as 
time spent immobile in the last 4 minutes of the test. (Mann-Whitney test). C) Water and sucrose 
consumption in the sucrose preference test in 11-12 week old WT and Atxn1154Q/2Q knockin mice. (2-way 
ANOVA). Data are presented as mean ± SD. 
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Atxn178Q/2Q mice 
Figure 5 shows learning and memory results in Atxn178Q/2Q mice. In contrast to the 
Atxn1154Q/2Q mice, the Atxn178Q/2Q mice were not appreciably different from wild type 
during the Barnes maze (Figure 5A-5C), as measured by path length (no significant effect 
of genotype [F(1,37) = 0.0059, P=0.9393] or genotype x day interaction [F(3,111) = 1.288, 
P=0.2821] by two-way RM ANOVA, n= 23 WT and 15 Atxn178Q/2Q mice) and strategy 
use during the training days (linear regression: WT: Y = 0.01851*X + 0.2491, 
Atxn178Q/2Q: Y = 0.0221*X + 0.1833, no significant difference between slopes of 
regression lines, F(1,625)=0.4012, p=0.5267, or between elevations, F(1,626)=1.845, 
p=0.1749),  as well as recall on the probe trial (t-test, WT average 33.33 sec in goal zone, 
n=23; Atxn178Q/2Q  average 34.75 sec, n=15). 
During context fear conditioning, Atxn178Q/2Q mice acquired freezing responses similarly 
to wild type (no effect of genotype by 2-way repeated measures ANOVA; F(1,40) = 
0.1055, P=0.7470, n = 20 WT and 20 Atxn178Q/2Q mice, Figure 5D). When tested for 
recall 24 hours later, Atxn178Q/2Q mice froze at wild-type levels in both the baseline and 
conditioned context (baseline context: WT average 18.28% freezing, Atxn178Q/2Q average 
19.69% freezing; conditioned context: WT average 56.87% freezing, Atxn178Q/2Q  average 
58.88% freezing, no significant effect of genotype [F(1,40) = 0.0913, P=0.7641] or 
genotype x context interaction [F(1,40) = 0.0090, P=0.9249] by 2-way RM ANOVA, n=20 
WT and 12 Atxn178Q/2Q  mice, Figure 5E). Together, these data suggest that ATXN1 with a 
polyglutamine tract of 78 repeats is not sufficient to cause the same learning deficits as 
the version with 154 repeats. 
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Figure 6 shows tests of mood in Atxn178Q/2Q mice. There was no significant difference 
between Atxn178Q/2Q mice and wild-type on any measure of the elevated plus maze, 
suggesting that they do not have an anxiety-like phenotype. (WT average time in open 
arms = 49.01 ± 4.184 sec, Atxn178Q/2Q average time in open arms = 53.41 ± 6.649 sec, 
p=0.1202; WT average time in closed arms = 122.3 ± 5.079 sec, Atxn178Q/2Q average time 
in closed arms = 121.3 ± 4.718 sec, p=0.8964; WT average time in center=131.1 ± 5.169 
sec, Atxn178Q/2Q average time in center =125.2 ± 4.34 sec, p=0.3959;  n=22 WT and 20 
Atxn178Q/2Q mice, t-tests, figure 6A.)  
We also did not observe a depressive-like phenotype in Atxn178Q/2Q mice as measured by 
the forced swim test (WT average time immobile=120.3 ± 7.271 sec, Atxn178Q/2Q average 
time immobile = 116.6 ± 5.753 sec, p=0.1202, n=24 WT and 17 Atxn178Q/2Q mice, t-test, 
Figure 6B). On the sucrose preference test (Figure 6C), we saw a significant effect of 
genotype by 2-way RM ANOVA (F(1,39) = 6.575, p=0.0143, n=20 WT and 21 Atxn1
78Q/2Q 
mice). Atxn178Q/2Q mice consumed more sucrose than wild-type (WT average 10.15 g, 
Atxn178Q/2Q average 12.7 g, p=0.0161) with no statistically significant difference in water 
consumption (WT average 5.21 g, Atxn178Q/2Q average 6.13 g, p=0.5498) much like the 
Atxn1154Q/2Q mice (see Figure 4C). This suggests that increased sucrose consumption, 
unlike other features of the Atxn1154Q/2Q model, can be caused by the shorter 78Q 
polyglutamine tract.  
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Figure 5. Atxn178Q/2Q mice perform at WT levels on tests of learning and memory. A) Barnes maze average path 
length on each of the four training days for 9-10 week old WT and Atxn178Q/2Q knockin mice (2-way ANOVA). 
B) Barnes maze probe trial (percent time spent in each zone) for 9-10 week old WT and Atxn178Q/2Q knockin mice (2-
way ANOVA). C) Barnes maze search strategy use (left) and corresponding cognitive scores (right) over the four 
training days in 9-10 week old WT and Atxn178Q/2Q knockin mice D) Acquisition of freezing responses during context 
fear conditioning in 10-11 week old WT and Atxn178Q/2Q knockin mice, reported as percent freezing during the 60-
second interval after each shock (2-way ANOVA). E) Fear conditioning 24 hour recall in a baseline context and the 
conditioned context for 10-11 week old WT and Atxn178Q/2Q knockin mice (2-way ANOVA). Data are presented as 
mean ± SD.)  
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Figure 6. Mood in Atxn178Q/2Q mice. A) Elevated plus maze in 8-9 week old WT and Atxn178Q/2Q knockin 
mice. The time spent in the open arms (left), closed arms (center) and center of the maze (right) is shown 
(t-test). B) Forced swim test in 8-9 week old WT and Atxn178Q/2Q  knockin mice, reported as time spent 
immobile in the last 4 minutes of the test (t-test). C) Water and sucrose consumption in the sucrose 
preference test in 11-12 week old WT and Atxn178Q/2Q   knockin mice. (2-way ANOVA). Data are presented 
as mean ± SD. 
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Chapter 3: Cognition and mood in PCP2-Atxn1[82Q] transgenic mice 
Introduction 
The fact that both Atxn1-/- and Atxn1154Q/2Q mice perform poorly on tests of cognition 
strongly suggests that ATXN1 impacts learning and memory, but provides little insight 
into how it does so. One possible explanation is that ATXN1 affects cerebellar function, 
as it does when causing motor deficits in Atxn1154Q/2Q mice and human SCA1 patients. 
The contribution of cerebellar dysfunction to ATXN1-mediated motor deficits in mice has 
been demonstrated using Pcp2-ATXN1[82] transgenic mice, which overexpress 
polyglutamine-expanded mutant ATXN1 specifically in cerebellar Purkinje neurons 
(Burright et al. 1995). Pcp2-ATXN1[82Q] mice also provide an excellent opportunity to 
test whether mutant ATXN1-induced Purkinje cell dysfunction causes cognitive deficits or 
mood disturbances in mice; however, we know of no previous study addressing cognition 
or mood in these mice. We therefore conducted tests of cognition and mood on Pcp2-
ATXN1[82Q] mice to determine whether ATXN1 also affects these nonmotor functions 
by affecting the cerebellum. 
Methods 
Animals. Pcp2-ATXN1[82Q] transgenic mice (hereafter referred to as ATXN1[82Q] 
mice) were a gift from the laboratory of Dr. Harry Orr. They are from a new transgenic 
line generated to replace the original B05 line (Burright et al. 1995) after the B05 line 
lost a significant portion of its CAG repeat tract through random mutation. These mice 
were generated on an FVB background and later backcrossed onto a C57/Bl6 
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background. All experimental mice tested negative for the homozygous Pde6 mutation 
which causes blindness in FVB mice. 8-12 week old male and female ATXN1[82Q] mice 
as well as their wild-type littermates were used. 
Behavioral tests and statistical analysis. The Barnes maze, context fear conditioning, 
elevated plus maze, forced swim, and sucrose preference tests were conducted and 
analyzed as described above (see Chapter 1), except that t-tests were used in place of one-
way ANOVA for comparisons between two groups. 
Excluded mice. No mice were excluded from the Barnes maze analysis. For fear 
conditioning, one ATXN1[82Q] mouse clung to the walls and avoided one of the 
conditioning shocks, two more ATXN1[82Q] mice were handled excessively after 
mistakenly being put in the chambers before the camera was calibrated and being taken 
back out again before testing, and one WT mouse escaped from the testing rig after 
conditioning and was excluded from further testing. Three mice, all ATXN1[82Q], fell 
from the elevated plus maze and were excluded from analysis. One WT mouse was 
excluded from the forced swim test because the software did not track it properly. On the 
sucrose preference test, one WT mouse was excluded after its cage flooded overnight 
from a leaky water bottle. 
Results 
In order to test the contribution of cerebellar dysfunction to learning and memory deficits 
in SCA1 model mice, we performed tests of cognition and mood on ATXN1[82Q] 
transgenic mice. These mice overexpress ATXN1 with 82 CAG repeats selectively in 
cerebellar Purkinje neurons under the Purkinje cell protein 2 (Pcp2) promoter. As with 
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the Atxn1154Q/2Q mice, we tested these mice from 8-12 weeks of age in the hopes of 
avoiding severe ataxia which could interfere with the interpretation of results. 
Figure 7 shows learning and memory results in ATXN1[82Q] transgenic mice. On the 
Barnes maze, ATXN1[82Q] mice were largely indistinguishable from wild type in terms 
of path length over the four training days (no significant effect of genotype [F(1,29) = 
1.529 P=0.2261] or genotype x day interaction [F(3,87) = 1.212, P=0.3103] by two-way 
RM ANOVA, n=15 WT and 16 ATXN1[82Q] mice, Figure 7A) and time in the goal zone 
on the probe trial (WT average 40.55 sec, n=15; ATXN1[82Q] average 37.56 sec, n=16; 
p=0.4060, t-test, Figure 7B). However, ATXN1[82Q] mice appeared to acquire spatial 
strategies more slowly than WT mice, as evidenced by a significantly lower slope on the 
regression line of their cognitive score over time (WT: Y = 0.02103*X + 0.1713, 
ATXN1[82Q]: Y = 0.007595*X + 0.166, significantly different slopes, F(1,491)=5.586, 
p=0.0185). This is puzzling given their wild-type-level performance on the probe trial, 
which indicates that they remember where to find the hole despite apparently not using 
search strategies that depend on that memory. One possible explanation is that it was 
relatively common for ATXN1[82Q] to find the escape box but continue exploring the 
maze rather than climbing in, a behavior which was somewhat common among our mice. 
Trials in which this happened were generally classified as “random” by the strategy 
analysis software, lowering the average cognitive score without affecting path length 
(which was measured as the length traveled before the first entry into the goal hole). If 
this was more common in the ATXN1[82Q] mice than in WT, it may explain the apparent 
difference in strategy use. This could mean that they actually have something other than a 
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learning deficit, such as a decreased fear of brightly lit spaces (see also the elevated plus 
maze results below) or subtle motor deficits which make it difficult for them to climb into 
the escape box without reducing their average walking speed. 
In context fear conditioning, ATXN1[82Q] mice acquired freezing responses at 
approximately the same rate as wild type mice during conditioning (no significant effects 
of genotype [F(1,22) = 0.03942, p=0.8444] or genotype x shock# interaction [F(4, 88)=1.023, 
p=0.4002] by 2-way RM ANOVA, n=12 WT and 12 ATXN1[82Q] mice, figure 7D). 
There was a trend towards ATXN1[82Q] mice freezing less than wild type in the 
conditioned context, but this was not statistically significant (baseline context: WT 
average 30.08% freezing, ATXN1[82Q] average 21.75% freezing; conditioned context: 
WT average 60.17% freezing, ATXN1[82Q] average 45.58% freezing; no significant 
effect of genotype by 2-way RM ANOVA [F(1,22) = 2.816, P=0.1075], n=12 WT and 12 
ATXN1[82Q] mice).  
Figure 8 shows mood results in ATXN1[82Q] mice. The elevated plus maze revealed a 
striking reduced anxiety phenotype in the ATXN1[82Q] mice: they spent significantly 
more time in the open arms (WT average 30.22 ± 4.745 sec, ATXN1[82Q] average 67.99 
± 9.448 sec, p=0.0047, t-test, n=11 WT and 8 ATXN1[82Q] mice) and less time in the 
closed arms (WT average 165.6 ± 5.257 sec, ATXN1[82Q] average 126.9 ± 10.58 sec, 
p=0.0079, t-test, n=11 WT and 8 ATXN1[82Q] mice) than wild-type, with some 
individuals showing little to no preference for the closed arms over the open arms (Figure 
8A).  
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We did not observe any differences between ATXN1[82Q] and wild-type mice in either 
the forced swim test (WT average 137.3 ± 8.064 sec, ATXN1[82Q] average 136.5 ± 9.38 
sec, p=0.9516, t-test, n=11 WT and 10 ATXN1[82Q] mice, Figure 8B) or the sucrose 
preference test (no significant effect of genotype [F(1,27) = 0.07114, P=0.7917] or 
genotype x sucrose interaction [F(1,27) = 0.6926, P=0.4126] by 2-way RM ANOVA, n=14 
WT and 15 ATXN1[82Q] mice, Figure 8C), suggesting that these mice do not have a 
strong depressive-like phenotype. 
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Figure 7. Cognition in PCP2-ATXN1[82Q] mice. A)  Barnes maze average path length on each of the four training 
days for 9-10 week old WT and Pcp2-ATXN1[82Q] mice (2-way ANOVA). B) Barnes maze probe trial (percent time 
spent in each zone) for 9-10 week old WT and Pcp2-ATXN1[82Q] mice (2-way ANOVA). C) Barnes maze search 
strategy use (left) and corresponding cognitive scores (right) over the four training days in 9-10 week old WT and 
Pcp2-ATXN1[82Q] mice. D) Acquisition of freezing responses during context fear conditioning in 10-11 week old WT 
and Pcp2-ATXN1[82Q] mice, reported as percent freezing during the 60-second interval after each shock (2-way 
ANOVA). E) Fear conditioning 24 hour recall in a baseline context and the conditioned context for 10-11 week old 
WT and Pcp2-ATXN1[82Q] mice. (2-way ANOVA). Data are presented as mean ± SD. 
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Figure 8. Mood in PCP2-ATXN1[82Q] mice. A) Elevated plus maze in 8-9 week old WT and Pcp2-
ATXN1[82Q] transgenic mice. The time spent in the open arms (left), closed arms (center) and center of the 
maze (right) is shown (t-test). B) Forced swim test in 8-9 week old WT and Pcp2-ATXN1[82Q] transgenic 
mice, reported as time spent immobile in the last 4 minutes of the test (t-test). C) Water and sucrose 
consumption in the sucrose preference test in 11-12 week old WT and Pcp2-ATXN1[82Q] transgenic mice 
(2-way ANOVA). Data are presented as mean ± SD. 
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Chapter 4: ATXN1 knockout reduces hippocampal neurogenesis 
Note regarding ownership and author contributions 
This chapter includes figures and text originally published in Neuroscience (Asher et al. 
2016) and reproduced here with permission from the journal. The methods and results 
sections were written jointly by me, Andrea Johnson, and Marija Cvetanovic, based on 
data collected by me (neurosphere culture, transfection, and BrdU assays; BrdU 
immunohistochemistry; Western blotting), Andrea Johnson (DAOY cell culture; cell 
cycle assays; RT-qPCR, Western blotting), Bojana Zecevic (immunohistochemistry) and 
David Pease (immunohistochemistry). The introduction has been rewritten by me for this 
thesis. 
Introduction 
In addition to characterizing the behavioral changes in ataxin-1 mutant mouse strains, we 
are interested in finding the cellular and molecular mechanisms of these changes—this 
will contribute to our understanding of ataxin-1’s endogenous function and could inform 
future studies aimed at understanding, treating, or preventing cognitive changes in 
humans with SCA1. However, given that the cerebellum-specific Pcp2-ATXN1[82Q] 
mutant showed little to no cognitive deficits on the tasks we used, it is likely that areas 
other than the cerebellum make the largest contributions to ataxin-1’s role in cognition. 
We therefore decided to examine the role of ATXN1 in the hippocampus, which is well 
known for its major contributions to learning and memory in both humans and rodents 
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(Scoville and Milner 1957), and is thought to be crucial for both spatial navigation 
(O’Keefe and Dostrovsky 1971) and context fear conditioning (Shima et al. 2013).  
The hippocampus performs many functions related to learning and memory. Our results 
focus on the process of hippocampal neurogenesis, or the generation of adult-born 
hippocampal granule neurons. Hippocampal neurogenesis continues throughout adult life. 
It depends on a pool of neural precursor cells (NPCs) in the subgranular zone of the 
hippocampal dentate gyrus, which consists of slowly dividing stem cells and more 
quickly dividing intermediate progenitor cells. Most of the dentate gyrus stem cells are 
quiescent at any given time, but they can enter the cell cycle and divide to give rise to 
intermediate progenitor cells. Intermediate progenitor cells undergo further divisions, 
differentiate into young neurons, and migrate a short distance into the granule cell layer, 
where they integrate into the neural circuitry (Deng et al. 2009; Christian, Song, and 
Ming 2014). For some time after being integrated, young adult-born neurons have unique 
circuit properties (Doetsch and Hen 2005). This allows them to contribute in unique ways 
to pattern separation, or distinguishing between similar inputs, which may be important 
for avoiding interference between new and old memories (Nakashiba et al. 2012; 
Johnston et al. 2015). 
The rate at which new neurons are generated has been linked to learning and memory in 
numerous previous studies (Jessberger et al. 2009; Ko et al. 2009; Braun and Jessberger 
2014; Shors et al. 2001; Dupret et al. 2008; Sahay et al. 2011). Hippocampal 
neurogenesis is also reduced in a number of disease states where cognition is impaired, 
including Alzheimer’s disease (Verret et al. 2007), Parkinson’s disease (Winner et al. 
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2004), and Huntington’s disease (Fedele et al. 2011). To begin testing whether this is also 
true in SCA1, we investigated the role of ataxin-1 in regulating adult hippocampal 
neurogenesis.  
Methods 
Animals. Atxn1−/− mice were generated as described (Matilla et al. 1998). Originally 
generated on a C57BL/6J–129/SvEv mixed background, these mice were backcrossed for 
more than ten generations with FVB mice to avoid confounding effects of genetic 
background. Because our previous studies have detected no sex-specific effects, we have 
used an equal mix of animals of both sexes for our experiments. All animal experiments 
were performed in compliance with the National Institutes of Health’s Guide for the Care 
and Use of Laboratory Animals and the University of Minnesota Institutional Animal 
Care and Use Committee. 
NPC culture. Hippocampal precursor cells were isolated from hippocampi of one-month-
old mice according to published isolation protocols (Bonaguidi et al. 2008). Briefly, 
dissected hippocampi of Atxn1−/− mice and their wild-type littermates were incubated in 
0.1% trypsin for 7 min at 37°C. Trypsin inhibitor (Sigma) was added to stop the 
digestion, and the cell suspension was passed through a 70-μm cell strainer. Cells were 
grown in neurosphere medium (DMEM/F12 with l-glutamine (Gibco) containing 
penicillin/streptomycin with l-glutamine (Gibco), heparin (Sigma), N2 (Gibco), B27 
(Gibco), 10 ng/mL human recombinant fibroblast growth factor (FGF, BD), 20 ng/mL 
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human recombinant epidermal growth factor (EGF, BD) and 250 ng/ml noggin (R&D)) 
at 37°C in non-adherent 24-well plates. 
Nucleofector4D transfection of neurospheres. Hippocampal precursor cells were isolated 
from one-month-old wild-type (FVB) or Atxn1−/− mice and grown as neurospheres. After 
being expanded in vitro for 4-7 passages, neurospheres were dissociated into a single-cell 
suspension using trypsin (0.05%) and mechanical trituration. Dissociated cells were 
transfected using the Lonza 4-D Nucleofector X Unit (Lonza) according to the 
manufacturer’s instructions. Briefly, 100,000–500,000 cells per condition were 
resuspended in 20 μl P3 solution (Lonza) and 1 μg of plasmid DNA (pEGFP-C2 with 
either ATXN1[82Q] or ATXN1[30Q] inserted into the EcoRI/SalI sites to make ATXN1 
with GFP fused to the C-terminal, or pEGFP-C2 alone as a control). The cell suspension 
was subjected to pulse code CU-110 and allowed to sit for 10 min at room temperature 
before being plated in neurosphere growth medium at a density of approximately 50,000 
cells/mL. 
5-bromo-2′-deoxyuridine (BrdU) administration and immunohistochemistry. BrdU 
(Sigma–Aldrich) was prepared at 20 mg/mL in sterile saline and injected 
intraperitoneally at a dose of 100 mg/kg every 12 h for three doses. Mice were euthanized 
48 h or one month after injection. Brains were harvested and post-fixed by incubation in 
4% paraformaldehyde overnight, and then incubated in 30% sucrose until saturation. 40-
μm-thick sections were cut using a cryostat (Leica 1900). Antigen retrieval was 
performed with 10 mM sodium citrate (pH 6) for 25 min at 100°C. The sections were 
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incubated for 1 h in blocking buffer (3% Normal Donkey Serum in PBST (pH 7.5, 50 
mM Tris-HCl, 145.5 mM NaCl, 1 % TritonX-100)) followed by overnight incubation at 
4°C in blocking buffer containing primary antibody (anti-NeuN (goat, Santa Cruz 
#SC8066), anti-ataxin1 (rabbit 11750, gift from Dr. Harry Orr), anti-Tbr2 (chicken, 
Millipore #AB15894) and anti-Sox2 (goat, Santa Cruz #sc-17320)). After being exposed 
to secondary anti-goat or anti-rabbit Alexa 594 conjugated antibody (Life Technologies), 
samples were fixed with 4% paraformaldehyde and treated with 5 M HCl in 0.1% 
TritonX-100 for 15 min to expose BrdU binding sites. After 5 washes in PBS, samples 
were incubated overnight in anti-BrdU antibody (rat, Bio-Rad #MCA2060) followed by 
secondary anti-rat Alexa 488 antibody. Samples were mounted using anti-fade mounting 
medium with DAPI (Vectashield, Vector) and analyzed using an Olympus FV1000 
confocal microscope. 
Western blot analysis. NPCs derived from Atxn1−/− mice and wild-type littermates were 
lysed in RIPA lysis buffer (50 mM Tris HCl, pH 7.4, 150 mM NaCl, 1% sodium 
deoxycholate, 1% NP-40, 0.2% SDS, phosphatase inhibitor (Sigma) and protease 
inhibitor cocktail (Roche)). Proteins were separated on a 12% SDS–PAGE gel and 
transferred onto a nitrocellulose membrane. The following primary antibodies were used: 
anti-ATXN1 (rabbit 11750 and 11NQ, gifts from Dr. Harry Orr’s laboratory), anti-cyclin 
D1 (mouse, Santa Cruz #20044; rabbit, Abcam #ab134175), and alpha-tubulin (mouse, 
Sigma). Signal from secondary antibodies linked to horseradish peroxidase (HRP) (GE 
Healthcare) was detected using Amersham ECL Western Blotting Detection Reagent (GE 
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Healthcare) and an ImageQuant LAS 4000 imager (GE Healthcare); protein levels were 
quantified using ImageQuant (GE healthcare) software. 
In vitro BrdU proliferation assay. A BrdU proliferation assay was performed using the 
BrdU Cell Proliferation Assay Kit (Cell Signaling) according to the manufacturer’s 
instructions. Neurospheres were trypsinized and mechanically dissociated into single-cell 
suspensions, and 10,000 NPCs were plated per well in non-adherent 96-well plates. BrdU 
solution was added at the time of cell plating and cells were allowed to grow for 24 h. To 
assay BrdU incorporation, cells were fixed and incubated with primary BrdU antibody 
for 1 h at RT, followed by incubation with HRP-conjugated secondary antibody for 30 
min. TMB substrate was added to the wells and absorbance was read at 450 nm using a 
dual-wavelength spectrophotometer (SPECTRAmax). Each experimental condition 
included 4–5 technical replicates and the experiment was performed on four independent 
biological isolates. 
Secondary neurosphere formation assay. Early passages (P1-P7) of NPCs were plated in 
non-adherent 96-well plates (BD 351172) at a density of 1000 cells/well, 8–12 wells per 
condition. After 7 days, neurospheres, defined as clumps of more than 16 cells, were 
imaged; neurospheres were counted and their diameter was measured using ImageJ 
(NIH). Neurospheres that had flat cells with processes spreading out of the spheres were 
counted as differentiating. 
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Statistical analysis. Data are presented as mean ± SEM. Statistical analysis was 
performed by Student’s t-test. Results are considered statistically significant when P < 
0.05. 
Results 
Ataxin-1 is expressed in hippocampal NPCs 
In light of the evidence linking ATXN1 to hippocampal learning in mice, we examined 
the expression pattern of ATXN1 in the hippocampus. Consistent with published data, we 
found that ATXN1 was strongly expressed in granule neurons of the dentate gyrus (Banfi 
et al. 1996; Servadio et al. 1995). Additionally, we found that ATXN1 was expressed in 
NPCs; here we use the term neural precursor cells to encompass neural stem cells 
(expressing sex determining region Y-box 2 (Sox2)) and neural progenitor cells 
(expressing T-box brain gene 2 (Tbr2)) (Bonaguidi et al. 2011; Hodge et al. 2012) 
(Figure 9A). Western blot analysis of lysates prepared from isolated precursor cells 
grown in vitro as neurospheres confirmed expression of ATXN1 in these cells (Figure 
9B). 
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Figure 9. ATXN1 is expressed in dentate gyrus. A) Confocal images of hippocampal dentate gyrus co-
stained for ATXN1 (green) and markers of neural precursor cells: (Sox2) (red, top right panel) and (Tbr2) 
(red, left and bottom right panel). Scale bars=50, 10, and 20 µm. B) Western blot of lysates prepared from 
neural precursor cells derived from Atxn1−/− and wild-type mice, labeled with anti-ataxin-1 and anti-alpha-
tubulin antibodies.  
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Hippocampal proliferation is progressively decreased in Atxn1−/− mice 
Expression of ATXN1 in precursor cells of the dentate gyrus suggests a potential function 
in adult hippocampal neurogenesis. To investigate this, we assessed proliferation in the 
dentate gyrus of Atxn1−/− mice with intraperitoneal injection of BrdU, a thymidine analog 
that is incorporated into the DNA during cell division. BrdU-immunoreactive cells were 
quantified in the dentate gyrus of the hippocampus by immunohistochemistry. One-
month-old Atxn1−/− mice already had 25% fewer BrdU+ cells in the dentate gyrus than 
wild-type controls (Figure 10A). This deficit worsened with age; at one month of age 
(postnatal day 30 (P30)) there was a 25% decrease (P = 0.0459), at two months (P60) a 
37% decrease (P = 0.0146), and at four months (P120) a 72% decrease (P = 0.0002) in 
the number of proliferating cells in the dentate gyri of Atxn1−/− mice compared to their 
wild-type littermates (Figure 10B). Co-labeling of BrdU-positive cells with markers of 
neural stem cells (glial fibrillary acidic protein (GFAP) and nestin) demonstrated that 
neural stem cells proliferate less in Atxn1−/− mice (data not shown). These data suggest 
that ATXN1 is required to maintain proliferation of hippocampal neural precursors. 
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Figure 10. Hippocampal proliferation is decreased in Atxn1-/- mice. A) Representative image of BrdU 
staining in Atxn1-/- mice and wild-type littermates. Scale bar=40 µm. B) The number of BrdU+ cells per 
dentate gyrus 48 h after the last BrdU injection in P30, P60 and P120 Atxn1-/- mice normalized to wild-type 
mice (Student’s t-test, P=0.0459, P=0.0146, and P=0.0002 respectively). N=3 mice per group. Error 
bars=SEM. 
 
 
55 
 
Decreased proliferation in the dentate gyrus of Atxn1−/− mice results in a reduced 
number of newly formed hippocampal neurons 
To determine whether the reduction in hippocampal proliferation ultimately affected the 
number of newly formed neurons—the final output of hippocampal neurogenesis—we 
birth-dated newborn neurons with intraperitoneal injections of BrdU and analyzed the 
brains one month later for co-expression of BrdU and the mature neuronal marker NeuN 
(Figure 11A). At both ages examined (one and two months at time of injection) Atxn1−/− 
mice had fewer newly generated BrdU+NeuN+ neurons in the dentate gyrus than their 
age-matched wild-type littermates. Furthermore, this reduction in newly generated 
hippocampal neurons worsened with age (P30: 25% decrease, P = 0.037, P60 75% 
decrease, P = 0.0004, Figure 11B) suggesting that lack of ATXN1 progressively reduces 
hippocampal neurogenesis. 
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Figure 11. Hippocampal neurogenesis is decreased in Atxn1-/- mice. A) Representative image of BrdU 
(isolated green nuclei) and NeuN (tightly-packed red nuclei) co-staining in Atxn1-/- mice and wild-type 
littermates. Scale bar=40 µm. B) The number of newborn mature neurons (BrdU+NeuN+) per dentate gyrus 
one month after BrdU injection into P30 and P60 Atxn1-/- mice, normalized to wild-type littermates 
(Student’s t-test, P=0.037 and P=0.004 respectively). N=3 mice per group. Error bars=SEM. 
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ATXN1 regulates hippocampal proliferation in a cell-autonomous manner 
Proliferation of NPCs is determined by the interaction of extrinsic and intrinsic factors 
(Faigle and Song 2013). For example, several factors are known to be released within the 
neurogenic niche from mature neurons to regulate the proliferation of NPCs (Ma et al. 
2009). Because ATXN1 is expressed both in neural precursors and in mature granule 
neurons, loss of ATXN1 could alter proliferation of NPCs either in a cell-autonomous 
manner and/or by environmental signals such as those from mature neurons. To test 
whether ATXN1 can regulate proliferation of cells in a cell-autonomous manner, we 
isolated hippocampal precursors from Atxn1−/− mice and cultured them in vitro as 
neurospheres (Figure 12A). An in vitro BrdU assay revealed decreased cell proliferation 
of NPCs derived from P30 Atxn1−/− mice (Figure 12B, 21% decrease, P = 0.0148, N = 4 
independent isolates). In a secondary neurosphere formation assay, the decreased 
proliferation potential of Atxn1−/− NPCs was evident by smaller neurospheres (Figure 
12C, 23% decrease in diameter, P = 0.0148, N = 5). This decreased proliferation potential 
was accompanied by a greater degree of differentiation, as defined by the presence of flat 
cells extending processes beyond the boundaries of the spheres (4.9% of wild-type 
spheres and 24.67% of Atxn1−/− spheres, P = 0.038, N = 5, Figure 12D). This suggests 
that ATXN1 regulates proliferation of NPCs in a cell-autonomous manner, although it 
does not rule out the possibility that ATXN1 also modulates neurogenesis indirectly by 
affecting granule neurons or other cells of the neurogenic niche (Ma et al. 2009; Song 
et al. 2012). NPCs isolated from two-month-old Atxn1−/− mice were also significantly 
impaired in the BrdU incorporation assay (50% decrease in BrdU incorporation, N = 3 
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independent isolates, P = 0.034, data not shown). The reduction in proliferation was 
greater in NPCs isolated from two-month-old Atxn1−/− mice than in those isolated from 
one-month-old Atxn1−/− mice (50% at two months vs 21% at one month); this suggests a 
progressive decrease in the intrinsic proliferative potential of Atxn1−/− hippocampal 
NPCs, in agreement with our in vivo results (Figures 10 and 11). Interestingly, half of our 
attempts to grow neurospheres from two-month-old Atxn1−/− mice were unsuccessful. In 
the remaining half of isolates, several passages were required to grow enough Atxn1−/− 
cells to perform a proliferation assay, compared to just one passage in cells isolated from 
wild-type littermates. Finally, expression of human wild-type ATXN1[30Q] in Atxn1−/− 
neurospheres rescued the proliferation deficit in the BrdU assay (Figure 12E, ∼20% 
increase compared to GFP transfected Atxn1−/− control, N = 3, P = 0.041), but did not 
significantly increase the diameter of Atxn1−/− neurospheres or prevent their 
differentiation (data not shown). 
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Figure 12. Neural precursor cells isolated from Atxn1-/- hippocampus proliferate less than wild-type 
cells in vitro. Neural precursor cells isolated from P30 Atxn1-/- mice and their wild-type littermates were 
grown in vitro. A) Bright-field image of WT and Atxn1-/- neurospheres. Scale bar=100 µm. B) An in vitro 
BrdU assay demonstrates decreased proliferation of Atxn1-/- precursors (Student’s t-test, P=0.0148). C) and 
D) Colonies formed from Atxn1-/- cells have decreased diameter compared to wild type (C) (Student’s t-
test, P=0.0148), as well as a higher degree of differentiation (D), defined by the presence of flat cells with 
processes extending out of the spheres (Student’s t-test, P=0.038). N=5 independent cultures of neural 
precursor cells. E) Transient transfection of wild-type ATXN1[30Q] increased BrdU incorporation of 
Atxn1-/- precursors. N=3 independent transfections. (Student’s t-test, P=0.041). Error bars=SEM. 
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To test whether the SCA1-causing polyglutamine expansion in ATXN1 also affects 
proliferation of NPCs, we used a Nucleofector 4D system to transiently transfect wild-
type neurospheres with plasmid vectors expressing GFP-tagged human mutant 
ATXN1[82Q], wild-type ATXN1[30Q] or GFP as a control. Expression of mutant 
ATXN1[82Q] significantly decreased BrdU incorporation in wild-type neurospheres 
(∼40% decrease compared to control GFP-transfected cells, N = 6 independent 
transfections, P = 0.0168, Figure 13A). Expression of wild-type ATXN1[30Q] caused a 
trend toward a decrease in BrdU incorporation (∼20% compared to GFP control, N = 3, P 
= 0.055, Figure 13A). In a secondary neurosphere formation assay, ATXN1[82Q]-
expressing NPCs formed smaller neurospheres than GFP controls (Figure 13B, ∼12% 
decrease in diameter, N = 3, P = 0.024), with a greater degree of differentiation 
(Figure 13C, 8.2% of GFP controls, 7.2% of ATXN1[30Q] transfected, and 12.4% of 
ATXN1[82Q] transfected spheres, N = 3, P = 0.031 comparing ATXN1[82Q] to GFP 
controls). Expression of wild-type ATXN1[30Q] did not affect the size or differentiation 
of neurospheres (Figure 13B, C). This data suggests that both loss of ataxin-1 and the 
polyglutamine expansion in ATXN1 reduce proliferation of NPCs. 
 
  
61 
 
 
Figure 13. Expression of mutant ATXN1[82Q] reduces proliferation of wild-type neural precursor 
cells. Neural precursor cells isolated from wild-type mice were transfected with plasmid vectors expressing 
mutant ATXN1[82Q], wild-type ATXN1[30Q] or control GFP. A) An in vitro BrdU assay demonstrates 
decreased proliferation upon ATXN1[82Q] expression compared to GFP controls. ATXN1[30Q] also 
showed a trend toward decrease. (Student’s t-test, P=0.0168 and P=0.055 for ATXN1[82Q] and 
ATXN1[30Q] respectively, N=6 or 3 independent transfections.) B) and C) Colonies formed from 
ATXN1[82Q]-transfected cells have decreased diameter (B, P=0.024) and higher degree of differentiation 
than wild type (C, P=0.031). N=4, 4, 2 for GFP, ATXN1[30Q] and ATXN1[82Q] transfections 
respectively. Error bars=SEM. 
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Discussion 
Table 1. Summary of results 
 
Strain 
Barnes 
Maze 
Fear 
conditioning 
EPM open 
arm time 
FST time 
immobile 
Sucrose 
preference 
Hippocampal 
Neurogenesis 
Atxn1-/- ↓ ↓ ↑ ↓ n.s. ↓ 
Atxn1+/- n.s. n.s. n.s. n.s. n.s.  
Atxn1154Q/2Q ↓ ↓ ↓ n.s. ↑ ↓1 
Atxn178Q/2Q n.s. n.s. n.s. n.s. ↑  
Pcp2-
ATXN1[82Q] 
n.s.2 n.s. ↑ n.s. n.s.  
 
Table 1. A summary of the major findings presented in chapters 1-4.  
 
Blank cells = not tested.  
n.s. = no significant difference between the listed strain and wild-type.  
Down arrows = less time in goal zone (Barnes maze probe trial), less time freezing (fear conditioning 24-
hour recall), less time in open arms and/or more time in closed arms (Elevated plus maze), less time spent 
immobile (forced swim test), decreased sucrose consumption (sucrose preference test), or reduced 
hippocampal neurogenesis.  
Up arrows = increased time in the open arms (elevated plus maze) or increased sucrose consumption 
(sucrose preference test). 
 
1 Cvetanovic, Hu, and Opal 2016. All other cells show results presented in this thesis. 
2 No significant difference in performance on the probe trial, but see chapter 3 for a discussion of 
differences in search behavior during the training trials.  
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SCA1 patients often experience cognitive deficits and mood alterations, but the root 
causes of these features of the disease have not been studied extensively, despite the 
availability of a variety of informative ATXN1 mutant mouse models. In order to better 
determine the role of ATXN1 in cognition and mood, we subjected several mouse strains 
with modifications in ATXN1 to a battery of behavioral tests. These included Atxn1+/- and 
Atxn1-/- mice to test haploinsufficiency and loss of function of ATXN1, Atxn1154Q/2Q and 
Atxn178Q/2Q mice to test the effects of polyglutamine expansions of different lengths, and 
Pcp2-ATXN1[82Q] mice to test the contribution of Purkinje cell dysfunction. The results 
are summarized in Table 1 on the previous page. This is the first time that these strains of 
mice have all been subjected to the same tests of mood and cognition in the same 
laboratory, allowing for better comparisons than ever before. 
We tested learning and memory in these mice using the Barnes maze and context fear 
conditioning. We found that Atxn1-/- and Atxn1154Q/2Q mice were both deficient in recall 
on these tests, in keeping with previous studies showing deficits on the Morris water 
maze in these mice (Matilla et al. 1998; Watase et al. 2002). For the Atxn1154Q/2Q mice, 
the deficits in the Barnes maze probe trial may be due to an issue with acquiring the task, 
as they failed to develop spatial search strategies during training. We saw no cognitive 
deficits in Atxn178Q/2Q knockin mice. This suggests that, similarly to motor deficits, 
cognitive deficits only arise in knockin mice with longer polyglutamine expansions than 
those seen in human patients.  
The presence of learning and memory deficits in both Atxn1-/- and Atxn1154Q/2Q mice 
suggests that these deficits are at least partially due to loss of ataxin-1 function rather 
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than a toxic gain of function in the 154Q allele. Importantly, however, heterozygous 
ATXN1 knockout mice performed normally on both Barnes maze and fear conditioning. 
Even a complete loss of function in the 154Q allele would be similar to a heterozygous 
knockout. Thus, the 154Q allele may function as a dominant negative, interfering with 
the function of the wild-type allele. This is further supported by the fact that the Barnes 
maze deficits during training were more severe in the Atxn1154Q/2Q mice than in the 
Atxn1-/- mice.  
The fact that heterozygous knockout mice perform normally suggests that a 50% decrease 
in ataxin-1 levels, such as that seen in experimental treatments aimed at reducing ataxin-1 
levels, would not cause cognitive side effects in wild-type mice. However, it will be 
important to determine whether this is true in mice with one allele expressing ATXN1 
with 78Q or 154Q, which are more similar to SCA1 patients and would be starting with 
some loss-of-function or dominant negative function before treatment. Experimentally 
reducing ataxin-1 levels in these mice will produce some combination of desirable effects 
(reducing any dominant-negative effects of the mutant allele) and undesirable effects 
(further knocking down the wild-type allele) on cognition. It may therefore be advisable 
to include tests of learning and memory when assessing the effects of preclinical 
treatments which reduce ataxin-1 levels. 
We did not see a significant deficit in performance on the Barnes maze or context fear 
conditioning in Pcp2-ATXN1[82Q] mice, suggesting that ATXN1 exerts its effects on 
cognition outside the cerebellar cortex, in contrast to its motor effects which are 
cerebellum-dependent (Burright et al. 1995). However, these mice did show unusual 
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behavior during training. They acquired spatial strategies slowly compared to wild-type 
mice. This may have been due to mice continuing to explore the maze despite having 
found the escape hole, which may indicate changes in their response to the open field or 
their ability to physically enter the hole. These changes could have interfered with the 
test, but further analysis is needed to quantify this behavior and determine whether there 
is a difference between genotypes. In addition, these more hippocampus-dependent tests 
may also fail to detect cerebellar cognitive deficits, which in humans are often related to 
executive function and working memory (for review see Koziol et al. 2014) rather than 
episodic memory, which would be more dependent on the hippocampus. Any future 
studies on cognition in these mice should therefore include tests of motor ability, such as 
the rotarod, beam cross, or Erasmus ladder, and tests of working memory, such as the 
alternating T-maze.  
Our mood tests focused on depression- and anxiety-like phenotypes. Despite the high 
prevalence of depression in SCA1 patients, we saw no evidence of a depression-like 
phenotype in any of our strains of mice. We did, however, see phenotypes in some strains 
which are not traditionally associated with a depression- or anxiety-like phenotype but 
which still may point to underlying changes in mood or motivation. These included the 
reduced immobility time on the forced swim test in Atxn1-/- mice, the increased sucrose 
preference in Atxn1154Q/2Q and Atxn178Q/2Q mice, and the increased time in the open arms 
of the elevated plus maze in Atxn1-/- and ATXN1[82Q] mice. 
Reduced immobility on the forced swim test is most often observed after treatment with 
antidepressants, and in juvenile rats this can remain long after treatment is discontinued 
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(Iñiguez, Warren, and Bolaños-Guzmán 2010). However, this does not necessarily mean 
that removing ataxin-1 has an “antidepressant” effect. The forced swim test ultimately 
measures the preference for a passive coping strategy (floating) over a more active escape 
strategy (swimming) when faced with an inescapable adverse situation (Commons et al. 
2017). Coping strategy can be affected by both environment (for example, chronic stress 
leading to a more passive strategy) and innate differences. A variety of poorly understood 
factors are involved in innate differences in immobility between strains. Our data suggest 
that ATXN1 may be among these factors. 
Interestingly, some genetic models of autism show reduced immobility in the forced 
swim test, though others may show increased immobility (Commons et al. 2017). This 
could be an interesting avenue of investigation given that humans lacking ATXN1 
develop autism spectrum disorders (Celestino-Soper et al. 2012). In addition, when CIC, 
a major binding partner of ATXN1, is deleted from the hypothalamus and lateral 
amygdala using Otp-cre, mice show abnormal social behavior (Lu et al. 2017). Two 
humans with mutations in CIC also showed autism spectrum disorders, although the 
sample size was small (Lu et al. 2017). However, much more work would need to be 
done on social cognition in Atxn1-/- mice to determine whether a connection to autism-
like behavior might exist. 
We attempted to investigate multiple aspects of a possible depressive-like phenotype by 
using a second test, the sucrose preference test, which measures anhedonia. However, 
none of our mice showed the decreased sucrose preference traditionally associated with a 
depressive-like phenotype. We saw increased sucrose preference in both Atxn1154Q/2Q and 
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Atxn178Q/2Q mice, suggesting that the 78Q polyglutamine tract is sufficient to cause 
changes in sucrose preference in mice. There was no change in sucrose preference in 
Pcp2-Atxn1[82Q] mice, suggesting that cerebellar cortical dysfunction is not sufficient to 
cause this effect. We did not observe a statistically significant change in Atxn1-/- mice. 
However, it is difficult to draw conclusions about loss vs gain of function from our 
Atxn1-/- data due to the small sample size and variability caused by leaks and spills during 
testing. An important next step would be to replicate this data in another group of mice 
not experiencing the technical difficulties we experienced. If true, the increased sucrose 
preference in Atxn1154Q/2Q and Atxn178Q/2Q mice could be caused by a number of things, 
such as an altered ability to taste sucrose, metabolic changes, or changes in motivation. 
Motivation in particular could be a promising avenue for future research. ATXN1 helps 
regulate the levels of the D2 dopamine receptor in the cerebellum (Goold et al. 2007). If 
this is true in the striatum as well, it could provide an explanation for the phenotype we 
see. 
Finally, we used the elevated plus maze to test for anxiety-like phenotypes in our mice. 
Atxn1154Q/2Q mice showed extreme individual variation in open arm time, but their 
slightly increased closed arm time and greatly decreased center time may suggest an 
anxiety-like phenotype. The 78Q allele was not sufficient to cause this, as Atxn178Q/2Q 
mice were no different from wild type. Interestingly, both Atxn1-/- and Pcp2-
ATXN1[82Q] mice showed an increase in open arm time relative to wild type, which was 
especially prominent in the Pcp2-ATXN1[82Q] mice. This was the only phenotype we 
observed that could be caused by expressing mutant ATXN1 in Purkinje neurons alone, 
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suggesting that the cerebellum may be involved in approach/avoidance behavior in mice. 
The abnormal behavior these mice showed during training for the Barnes maze may also 
be consistent with a reduced fear of brightly lit, exposed spaces. This reduced fear in 
Pcp2-ATXN1[82Q] mice is somewhat reminiscent of the human cerebellar cognitive 
affective syndrome (CCAS), which leads to impulsiveness and risky behavior 
(Schmahmann and Sherman 1998), but this is purely speculative at this stage. Any 
research into CCAS in mice will likely need to rely on a battery of tests and controlled 
cerebellar lesions. 
What could be the cellular mechanism(s) by which ATXN1 affects behavior? We have 
begun to investigate this question with a focus on how loss of ATXN1 might affect 
learning and memory. The hippocampus is a good candidate region for investigation, as 
both of the learning and memory tests we used—Barnes maze and context fear 
conditioning—rely heavily on hippocampal function. Our data show that hippocampal 
neurogenesis is reduced in Atxn1-/- mice (Asher et al. 2016). This is also true of 
Atxn1154Q/2Q mice (Cvetanovic, Hu, and Opal 2016).  
There are several possible mechanisms for ATXN1’s role in neurogenesis. First, ataxin-1 
could affect the survival of either stem cells or their progeny. However, we did not 
observe an increase in cell death in our Atxn1-/- neurospheres, as measured by live/dead 
cell counts and Western blotting for caspase-3 expression (data not shown). This argues 
against caspase 3-dependent cell death as a major mechanism of reduced neurogenesis 
but does not exclude the possibility that cell death could occur in vivo and/or through 
caspase 3-independent mechanisms. 
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Even if it does not affect survival, ATXN1 could affect the number of available NPCs by 
affecting their differentiation or self-renewal, as evidenced by the increased degree of 
differentiation we saw in Atxn1-/- neurospheres. It is worth noting that ataxin-1 suppresses 
the Notch signaling pathway in Drosophila (Tong et al. 2011), which regulates 
maintenance of neural stem cells (Giachino and Taylor 2014). ATXN1 also regulates 
expression of Tgfβ (Crespo-Barreto et al. 2010), which is a critical regulator of NPC 
differentiation (Chen et al. 2013; Tapia-González et al. 2013; Daynac et al. 2014). 
Finally, ATXN1 could be involved in controlling cell cycle entry or progression, thus 
directly affecting the frequency or rate of cell divisions. There is a growing body of 
literature showing that ATXN1 could affect the cell cycle at multiple points. First, the 
ataxin-1 protein physically interacts with several regulators of cell cycle progression 
(Hosp et al. 2015). These include Cdc16 and Bub3, which are components of the spindle 
assembly checkpoint at the metaphase/anaphase transition (Passmore et al. 2005; Han et 
al. 2014; Huang and Bonni 2016); Cdk1, which among other things helps to control entry 
into mitosis and later into anaphase (Gavet et al. 2010; Fujimitsu, Grimaldi, and Yamano 
2016); and Cdk2, which functions at the G1/S phase transition (Malumbres and Barbacid 
2005). The G1/S phase transition in particular is also regulated by other proteins which 
may be under the control of ATXN1. In flies, ATXN1’s binding partner Capicua controls 
expression of Cyclin E, the cyclin which associates with Cdk2 during the G1/S phase 
transition (Krivy, Bradley-Gill, and Moon 2013). In addition, ATXN1 regulates 
transcription of Cyclin D1 (Crespo-Barreto et al. 2010), a major regulator of progression 
through G0/G1 into S phase (Baldin et al. 1993). Interestingly, we have found that 
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Cyclin D1 levels are reduced in hippocampal NPCs from Atxn1-/- mice, and that the 
percentage of cells in the G0/G1 phase is increased at the expense of S phase (Asher et al. 
2016). This may indicate that ATXN1 affects entry into the cell cycle via Cyclin D1, 
Cyclin E, or Cdk2. However, further work is needed to determine whether the reduced 
Cyclin D1 levels are a cause or an effect of the ATXN1-mediated decrease in 
proliferation, and whether Cyclin E and Cdk2 are affected in NPCs.  
Neurogenesis makes important contributions to hippocampal plasticity and learning 
(Christian, Song, and Ming 2014), so the deficit in neurogenesis could contribute to the 
behavioral phenotypes we have found in Atxn1-/- and Atxn1154Q/2Q mice. However, it is 
likely not the only way that ATXN1 affects hippocampal function. Indeed, previous 
studies have shown reduced hippocampal dendritic arborization in Atxn1154Q/2Q mice 
(Watase et al. 2007) and deficits in hippocampal paired-pulse facilitation in Atxn1-/- mice 
(Matilla et al. 1998). Beyond the hippocampus, ataxin-1 and its binding partner Capicua 
also affect cortical thickness (Lu et al. 2017). In the future, it will be important both to 
determine the relative contributions of each of these processes to ataxin-1’s effect on 
behavior in vivo and to elucidate the molecular mechanisms for further study and/or 
treatment. This effort would benefit greatly from an ATXN1 flox mouse line, which does 
not yet exist but would make it much easier to test ATXN1 function in specific regions 
through conditional deletion. 
This thesis research helps to establish cognition, mood, and the regulation of adult 
hippocampal neurogenesis as important endogenous functions of ATXN1. Future basic 
science research can delve further into the molecular mechanisms of these effects, 
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helping to fill out our knowledge of the many processes controlled by ATXN1. From a 
clinical standpoint, this research is relevant both to SCA1, in which patients may 
experience cognitive deficits, and to other diseases including Alzheimer’s disease, where 
ATXN1 may contribute to risk (Bertram et al. 2008). Future translational research can 
focus on improving cognition in these diseases and avoiding cognitive side effects of 
treatments which manipulate ATXN1. 
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